London, United Kingdom

Paul Stroobant


Average Co-Inventor Count = 6.6

ph-index = 7

Forward Citations = 207(Granted Patents)


Location History:

  • London, GB (1996 - 2009)
  • Half Moon Bay, CA (US) (1998 - 2011)

Company Filing History:


Years Active: 1996-2011

Loading Chart...
20 patents (USPTO):Explore Patents

Title: **The Innovative Contributions of Paul Stroobant in Glial Cell Research**

Introduction

Paul Stroobant, based in London, GB, is a prominent inventor with an impressive portfolio of 20 patents. His work predominantly focuses on glial cell research, particularly in the context of mitogenesis and the treatment of glial cell tumors. Through his innovative research, he has contributed significantly to therapeutic and diagnostic advancements in this field.

Latest Patents

One of Paul Stroobant's notable patents is titled "Glial mitogenic factors, their preparation and use." This patent details the characterization and purification of DNA encoding a variety of polypeptides that stimulate the mitogenesis of glial cells, particularly Schwann cells. Additionally, it discusses DNA sequences that encode novel polypeptides with potential therapeutic applications in treating glial cell tumors. The patent also outlines methods for the synthesis, purification, and testing of both known and newly identified polypeptides, emphasizing their use as therapeutic and diagnostic aids for diseases involving glial cells. Furthermore, the methods provided include the preparation of antibody probes for both diagnostic and therapeutic purposes related to glial cell conditions.

Career Highlights

Paul's career includes significant roles at various esteemed institutions. He has worked with the Ludwig Institute for Cancer Research Limited and Acorda Therapeutics, Inc., where his research has led to pivotal advancements in glial cell therapy. His groundbreaking contributions have positioned him as a key figure in the field of biomedical innovation.

Collaborations

In his professional journey, Paul Stroobant has collaborated with notable individuals such as Andrew David Goodearl and Michael Derek Waterfield. These collaborations have fostered an environment of innovation and creativity, further enhancing the impact of his research.

Conclusion

Paul Stroobant exemplifies the spirit of innovation in his field. With 20 patents to his name and a commitment to researching glial cell mitogenesis and tumor treatment, he continues to pave the way for new therapies and diagnostic tools. His contributions not only highlight the importance of collaboration but also demonstrate the potential for scientific advancements through dedicated research and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…